We are live on ! Find out more
ACHN

Achillion Pharmaceuticals
ACHN

Delisted

ACHN was delisted on the 27th of January, 2020.

Back to rankings

162 hedge funds and large institutions have $873M invested in Achillion Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 57 increasing their positions, 44 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

196% more call options, than puts

Call options by funds: $13M | Put options by funds: $4.38M

178% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 9

30% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 44

10% more funds holding

Funds holding: 147 → 162 (+15)

2% more capital invested

Capital invested by funds: $852M → $873M (+$20.3M)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
162
Holders Change
+15
Holders Change %
+10.2%
% of All Funds
4.32%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
25
Increased
57
Reduced
44
Closed
9
Calls
$13M
Puts
$4.38M
Net Calls
+$8.59M
Net Calls Change
+$2.19M

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$12.9M
2
O
OrbiMed
New York
+$12.1M
3
PA
Perceptive Advisors
New York
+$7.9M
4
TCP
Tourbillon Capital Partners
New York
+$7.88M
5
NI
Numeric Investors
Massachusetts
+$7.6M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$37.4M
2
Millennium Management
Millennium Management
New York
-$26.9M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$16.4M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$15.9M
5
JP Morgan Chase
JP Morgan Chase
New York
-$5.14M
Name Holding Trade Value Shares
Change 		Change in
Stake
NI
26
Numeric Investors
Massachusetts
$7.24M +$7.6M +894,102 New
Axa
27
Axa
France
$6.73M -$870K -102,264 -11%
OAM
28
Oxford Asset Management
United Kingdom
$6.53M +$6.85M +805,967 New
Invesco
29
Invesco
Georgia
$6.48M +$201K +23,654 +3%
TA
30
Teachers Advisors
New York
$6.21M +$4.92M +578,300 +308%
SDIC
31
South Dakota Investment Council
South Dakota
$5.43M – – –
Arrowstreet Capital
32
Arrowstreet Capital
Massachusetts
$5.41M +$5.68M +668,185 New
Connor, Clark & Lunn Investment Management (CC&L)
33
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$4.6M -$2.35M -276,440 -33%
Renaissance Technologies
34
Renaissance Technologies
New York
$4.48M +$4.7M +552,600 New
Asset Management One
35
Asset Management One
Japan
$4.18M -$441K -51,852 -9%
Bank of America
36
Bank of America
North Carolina
$4.17M +$123K +14,434 +3%
Bank of New York Mellon
37
Bank of New York Mellon
New York
$4.15M -$246K -28,960 -5%
Charles Schwab
38
Charles Schwab
California
$3.57M +$183K +21,490 +5%
BIM
39
BlackRock Investment Management
Delaware
$3.55M +$5.73K +674 +0.2%
VMI
40
VHCP Management II
New York
$3.4M +$3.57M +420,000 New
HI
41
HBK Investments
Texas
$3.04M +$2.1M +247,500 +193%
Morgan Stanley
42
Morgan Stanley
New York
$2.94M +$2.09M +246,308 +211%
BA
43
BlackRock Advisors
Delaware
$2.47M +$1.03M +120,616 +66%
GC
44
Guggenheim Capital
Illinois
$2.38M +$133K +15,621 +6%
Citadel Advisors
45
Citadel Advisors
Florida
$2.37M +$1.64M +193,451 +196%
PP
46
PDT Partners
New York
$2.31M -$5.95K -700 -0.2%
QI
47
QS Investors
New York
$2.25M – – –
Capital Fund Management (CFM)
48
Capital Fund Management (CFM)
France
$2.17M +$2.28M +268,391 New
RPAM
49
Rhenman & Partners Asset Management
Sweden
$2.15M – – –
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
$2.01M +$16.2K +1,900 +0.8%
1
2
3 4 5

ACHN Hedge Fund Activity: Q3 2016 in Review

162 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Achillion Pharmaceuticals (ACHN) for Q3 2016, worth a combined $873M — up 2.4% from $852M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new ACHN positions and 9 closed out — a net gain of 16 holders — while 57 added to existing stakes and 44 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $12.9M. The largest seller was Fidelity Investments, cutting an estimated $37.4M.

  • 162 institutional investors held Achillion Pharmaceuticals (ACHN) as of Q3 2016, up from 147 in Q2 2016.
  • Funds reported $873M of Achillion Pharmaceuticals stock for Q3 2016, up 2.4% quarter-over-quarter.
  • 25 funds opened new Achillion Pharmaceuticals positions in Q3 2016 and 9 closed out, a net change of +16 holders.
  • The largest Achillion Pharmaceuticals buyer in Q3 2016 was Goldman Sachs, an estimated $12.9M added.
  • The largest Achillion Pharmaceuticals seller in Q3 2016 was Fidelity Investments, an estimated $37.4M sold.

Based on aggregated 13F filings for Q3 2016.